Cargando…
A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant
BACKGROUND: Bedaquiline is a core drug for treatment of rifampicin-resistant tuberculosis. Few genomic variants have been statistically associated with bedaquiline resistance. Alternative approaches for determining the genotypic-phenotypic association are needed to guide clinical care. METHODS: Usin...
Autores principales: | Anlay, Degefaye Zelalem, Rivière, Emmanuel, Tu, Pham Hien Trang, Abrams, Steven, Van Rie, Annelies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266631/ https://www.ncbi.nlm.nih.gov/pubmed/37315052 http://dx.doi.org/10.1371/journal.pone.0287019 |
Ejemplares similares
-
Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis: insights from a qualitative study
por: Tu, Pham Hien Trang, et al.
Publicado: (2022) -
Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study
por: Aemro, Agazhe, et al.
Publicado: (2020) -
Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis
por: Ismail, Nabila, et al.
Publicado: (2021) -
Rate of initial highly active anti-retroviral therapy regimen change and its predictors among adult HIV patients at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow up study
por: Anlay, Degefaye Zelalem, et al.
Publicado: (2016) -
Late ART Initiation among adult HIV patients at university of Gondar Hospital, NorthWest Ethiopia
por: Anlay, Degefaye Zelalem, et al.
Publicado: (2019)